Is it okay to stop taking venetoclax/venetoclax every 28 days?
Venetoclax/Venetoclax is a targeted therapy drug used to treat certain types of leukemia (such as chronic lymphocytic leukemia). It binds to B-cell lymphoma factor 2 (BCL-2) and inhibits the anti-apoptotic effect of BCL-2, thereby inducing tumor cell apoptosis. The dosage regimen of venetoclax usually needs to be determined based on the patient's specific situation and the doctor's advice.
The medication regimen of Venetoclax is not static, but needs to be individually adjusted based on the patient's disease type, severity of illness, physical condition, drug response and other factors. Therefore, a medication regimen of discontinuing medication every 28 days is not universally applicable.

The dosage and use of venetoclax are determined by the doctor based on the patient's condition and condition. In treatment regimens, venetoclax is usually administered continuously, taken orally once daily, until the treatment goals specified by your doctor are achieved or intolerable side effects occur. The therapeutic effect of Veneclatra takes a certain amount of time to manifest, and frequent discontinuation of the drug may affect the therapeutic effect. If the patient experiences adverse reactions or his condition improves during medication, the doctor may adjust the medication plan according to the specific situation, but this does not mean that it is reasonable to discontinue the medication every 28 days.
Additionally, the side effects of venetoclax are something to consider. Although this drug has achieved significant results in the treatment of leukemia, it may also cause some adverse reactions, such as thrombocytopenia, neutropenia, etc. Therefore, during medication, patients need to closely monitor their physical condition and report any discomfort or abnormal reactions to their doctor in a timely manner.
Finally, the medication regimen should be formulated and adjusted by the physician based on the patient's specific conditions. Patients should not decide to discontinue medication or change their medication regimen on their own to avoid adverse effects on treatment effects.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)